Department of Anesthesiology and Pain Medicine, Wonkwang University School of Medicine, 344-2 Sinyong-dong, Iksan, 570-711, Korea.
J Anesth. 2013 Feb;27(1):29-34. doi: 10.1007/s00540-012-1473-8. Epub 2012 Sep 11.
Some antiemetics are effective in the treatment of postoperative pain and shivering, as well as for postoperative nausea and vomiting (PONV). The aim of this study was to investigate the effects of ramosetron and dexamethasone on PONV, pain, and shivering and to determine the correlations between nausea, pain, and shivering.
For this study, 123 patients scheduled for thyroid surgery were randomly allocated to one of three groups: the control group (group C, n = 41), dexamethasone group (group D, n = 41), or the ramosetron group (group R, n = 41). The patients were treated intravenously with 2 mL of 0.9 % NaCl, 2 mL of 5 mg/mL dexamethasone, or 2 mL of 0.15 mg/mL ramosetron immediately after anesthesia.
The overall incidence and severity of postoperative nausea and the level of antiemetic consumption were significantly lower in group R compared with group D, and these parameters were significantly lower in groups R and D than in group C. There were significant differences in the incidence and severity of shivering, severity of pain, and analgesic consumption between group C and group R or D, but the incidence of shivering, pain severity, and analgesic consumption did not differ between groups R and D. The severity of shivering was significantly lower in group R than in group D. The correlation coefficients for shivering and pain, shivering and nausea, and pain and nausea were 0.210 (P = 0.010), 0.106 (P = 0.198), and 0.190 (P = 0.035), respectively, in group C.
Two antiemetic drugs, ramosetron and dexamethasone, significantly reduced the incidence and severity of postoperative nausea and the need for administration of rescue antiemetic drugs. Furthermore, both drugs effectively decreased the severity of pain and shivering. Ramosetron was superior to dexamethasone for reducing nausea, antiemetic consumption, and the severity of nausea, but not for reducing the incidence of shivering. Further studies are required to elucidate the correlations between postoperative nausea, pain, and shivering, as a statistically significant but weak correlation was shown in the present study.
一些止吐药可有效治疗术后疼痛和寒战,以及术后恶心和呕吐(PONV)。本研究旨在探讨雷莫司琼和地塞米松对 PONV、疼痛和寒战的影响,并确定恶心、疼痛和寒战之间的相关性。
本研究纳入了 123 例行甲状腺手术的患者,将其随机分为三组:对照组(C 组,n=41)、地塞米松组(D 组,n=41)和雷莫司琼组(R 组,n=41)。麻醉后,三组患者分别静脉输注 2mL0.9%氯化钠、2mL5mg/mL 地塞米松或 2mL0.15mg/mL 雷莫司琼。
R 组患者术后恶心的总发生率和严重程度以及止吐药的使用量明显低于 D 组,且 R 组和 D 组均明显低于 C 组。C 组和 R 组或 D 组在寒战的发生率和严重程度、疼痛严重程度和镇痛药的使用量方面存在显著差异,但 R 组和 D 组之间的寒战发生率、疼痛严重程度和镇痛药的使用量无差异。R 组的寒战严重程度明显低于 D 组。在 C 组中,寒战与疼痛、寒战与恶心以及疼痛与恶心之间的相关系数分别为 0.210(P=0.010)、0.106(P=0.198)和 0.190(P=0.035)。
两种止吐药,雷莫司琼和地塞米松,可显著降低术后恶心的发生率和严重程度以及需要使用解救性止吐药的概率。此外,两种药物均能有效减轻疼痛和寒战的严重程度。雷莫司琼在降低恶心、止吐药的使用量和恶心的严重程度方面优于地塞米松,但在降低寒战的发生率方面则无优势。还需要进一步的研究来阐明术后恶心、疼痛和寒战之间的相关性,因为本研究显示两者之间存在统计学上显著但较弱的相关性。